Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.020
-0.020 (-0.98%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $111.85 million as of August 27, 2026. Its market cap has decreased by -9.36% in one year.
Market Cap
111.85M
Enterprise Value
-18.61M
1-Year Change
-9.36%
Ranking
Category
Stock Price
$2.02
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $111.85M, a decrease of -96.58%. That is a compound annual growth rate of -44.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 111.85M | 8.66% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 121.44M |
| Nautilus Biotechnology | 119.29M |
| Fractyl Health | 117.33M |
| Rani Therapeutics Holdings | 117.29M |
| Coya Therapeutics | 114.24M |
| NeOnc Technologies Holdings | 113.35M |
| Yarrow Bioscience | 110.98M |
| Oncolytics Biotech | 109.10M |